These rankings are based on data from September 2026

Company

CEPHALGO SAS

Years in business

  • 5

Number of employees

  • 1-10 employees

Country

  • France

Cephalgo develops speech biomarker software that maps short voice recordings to clinical scales used in CNS trials, including MMSE/MoCA for Alzheimer's and MDS-UPDRS for Parkinson's. It also processes recordings from participants' own devices or existing study recordings, with trial QC and EEG offerings.

API Availability

  • Unknown

MCP connector

  • Unknown

Pricing

unknown

Ranking position over time

October 2025 - September 2026

#22,981

Best rank

#22,981

Lowest rank

Stable over 1 month

12-month trend

#22,165

Best rank

#22,165

Lowest rank

Stable over 1 month

12-month trend

Use

biomarker analysis

clinical research

Industries

Human health and social work activities

Professional, scientific and technical activities

Security protocols

access controls

encryption in transit

gdpr

L3 category names

Emotion Recognition

Help us improve this profile

Insights

Maps

Social Media

© 2026 RankmyAI is licensed under CC BY 4.0
and is part of:

logo HvA

Get free insights in your inbox: